UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas

Frontiers in oncology, 2021-07, Vol.11, p.700568

2021

Volltextzugriff (PDF)

Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer

International journal of molecular sciences, 2021-08, Vol.22 (16), p.9030

2021

Volltextzugriff (PDF)

NRG1 Gene Fusions—What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications

Cancers, 2024-08, Vol.16 (15), p.2766

2024

Volltextzugriff (PDF)

Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer

Cancers, 2022-04, Vol.14 (7), p.1813

2022

Volltextzugriff (PDF)

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Frontiers in oncology, 2020-12, Vol.10, p.569202-569202

2020

Volltextzugriff (PDF)

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer

Life (Basel, Switzerland), 2022-10, Vol.12 (10), p.1640

2022

Volltextzugriff (PDF)

Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients

Cancers, 2024-02, Vol.16 (4), p.782

2024

Volltextzugriff (PDF)

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer

BMC cancer, 2022-09, Vol.22 (1), p.1-1001, Article 1001

2022

Volltextzugriff (PDF)

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5893

2024

Volltextzugriff (PDF)

CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples

Nature communications, 2019-10, Vol.10 (1), p.4732-12, Article 4732

2019

Volltextzugriff (PDF)

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

Frontiers in oncology, 2020-11, Vol.10, p.568081-568081

2020

Volltextzugriff (PDF)

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2061

2021

Volltextzugriff (PDF)

Preventing central nervous system metastases in non-small cell lung cancer

Expert review of anticancer therapy, 2018-11, Vol.18 (11), p.1077-1083

2018

Volltextzugriff (PDF)

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients

Cancer medicine (Malden, MA), 2020-01, Vol.9 (2), p.605-614

2020

Volltextzugriff (PDF)

Screening for gene mutations in central nervous system metastases of non‐small‐cell lung cancer

Brain pathology (Zurich, Switzerland), 2018-03, Vol.28 (2), p.295-297

2018

Volltextzugriff (PDF)

Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients

Archives of medical science, 2021, Vol.17 (2), p.474-480

2021

Volltextzugriff (PDF)

Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer

Brain pathology (Zurich, Switzerland), 2018-01, Vol.28 (1), p.77-86

2018

Volltextzugriff (PDF)

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer

Brain tumor pathology, 2017, Vol.34 (1), p.36-41

2017

Volltextzugriff (PDF)

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer

Oncology letters, 2019-06, Vol.17 (6), p.5193-5200

2019

Volltextzugriff (PDF)

PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

Anticancer research, 2016-05, Vol.36 (5), p.2243-2249

2016

Volltextzugriff (PDF)

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

Cancer genetics, 2019-09, Vol.237, p.10-18

2019

Volltextzugriff (PDF)

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

Oncotarget, 2017-09, Vol.8 (38), p.64283-64293

2017

Volltextzugriff (PDF)

Letter to the editor concerning first-line therapy with afatinib - an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations

Contemporary oncology (Poznań, Poland), 2015-01, Vol.19 (3), p.250-251

2015

Volltextzugriff (PDF)

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

JTO clinical and research reports, 2022-12, Vol.3 (12), p.100435-100435, Article 100435

2022

Volltextzugriff (PDF)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Pathology oncology research, 2014-01, Vol.20 (1), p.107-112

2014

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(35)
Oncology
(22)
Humans
(16)
Lung Cancer
(15)
Mutation
(15)
Female
(11)
Male
(11)
Patients
(11)
Middle Aged
(10)
Aged
(9)
Lung Neoplasms - Genetics
(9)
Medicin Och Hälsovetenskap
(9)
Nsclc
(9)
Tumors
(9)
Metastasis
(8)
Non-Small Cell Lung Carcinoma
(8)
Carcinoma, Non-Small-Cell Lung - Genetics
(7)
Lung Neoplasms - Pathology
(7)
Immunotherapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas

Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer

NRG1 Gene Fusions—What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications

Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer

Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection

CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study

Preventing central nervous system metastases in non-small cell lung cancer

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients

Screening for gene mutations in central nervous system metastases of non‐small‐cell lung cancer

Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients

Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer

PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

Letter to the editor concerning first-line therapy with afatinib - an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Suchergebnisse filtern